“…Table 1 summarises the current literature of ALD gene mutations and indicates molecular and clinical information about each mutation. Approximately 50% of mutations described to date are missense mutations, with the remainder nonsense mutations leading to premature termination of translation (12/110) Uchiyama et al, 1994;Fanen et al, 1994;Fuchs et al, 1994;Braun et al, 1995;Kok et al, 1995;Watkins et al, 1995;Rowland et al, 1996;Krasemann et al, 1996;Feigenbaum et al, 1996), microdeletions (18/110) Kemp et al, 1994;Barceló et al, 1994;Fuchs et al, 1994;Kok et al, 1994;Fanen et al, 1994;Song et al, 1995;Braun et al, 1995;Krasemann et al, 1996;Feigenbaum et al, 1996), microinsertions (3/110) (Krasemann et al, 1996;Feigenbaum et al, 1996), amino acid deletions (4/ 110) (Koike et al, 1994;Ligtenberg et al, 1995;Braun et al, 1995;Watkins et al, 1995;Krasemann et al, 1996), amino acid insertions (2/110) (Krasemann et al, 1996;Feigenbaum et al, 1996), and missense mutations leading to RNA splice site defects (5/110) Fanen et al, 1994;Feigenbaum et al, 1996). One "samesense" mutation has been documented (Fanen et al, 1994;Fuchs et al, 1994), which has been suggested as an alternate sequence or silent polymorphism.…”